SensoDetect operates in the healthcare sector. The company specializes in developing medical equipment that is used to analyze how a patient's brain reacts to sound stimuli. The technology is used in psychiatry to distinguish potential mental illnesses. The product consists of electrodes that are attached to the patient's head and then analyze brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is headquartered in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Inger Holmgren | 11,77 | 11,77 | 2026-03-27 |
| Nordnet Pensionsförsäkring | 8,01 | 8,01 | 2026-03-27 |
| Nowo Fund Management AB | 4,99 | 4,99 | 2026-03-31 |
| Avanza Pension | 4,31 | 4,31 | 2026-03-27 |
| Karl Vilhelm Gustaf Lundin | 3,56 | 3,56 | 2026-03-27 |
| Johan Möllerström med bolag | 3,33 | 3,33 | 2026-03-27 |
| Tore Robertsson | 3,14 | 3,14 | 2026-03-27 |
| Per-Anders Hedin | 2,96 | 2,96 | 2025-07-07 |
| Joachim Runesson | 2,23 | 2,23 | 2026-03-27 |
| Anna Caroline Holmgren | 2,18 | 2,18 | 2026-03-27 |
2026-05-05 Interim Report 2026-Q1
2026-05-28 Annual General Meeting 2025
2026-08-29 Interim Report 2026-Q2
2026-11-13 Interim Report 2026-Q3
2027-02-19 Year End Report 2026
2027-05-28 Annual General Meeting 2026
